PATENT CLAIM ANALYSIS

Application Number: 15881392
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-10
Patent Classification: ["424", "135100"]

Abstract:
The invention relates to antibodies, antibody fragments and binding agents that specifically recognize oligomeric tau but do not bind to monomeric tau, fibrillar tau or non-disease associated forms of tau.

Claim (Index 22):
The binding molecule of  claim 21 , wherein the binding molecule comprises at least one complementarity domain region (CDR) having an amino acid sequence TSGMH, FILHDGSDKYYADSVYG, SQRELLGAEYLQN, TGTSSDVGGYKYVS, DVSNRPS, and SSYTSSSTLV of SEQ ID NO:1.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 86.0
- Lexical Diversity: 1.17857
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15479110', '15424444', '14434742', '15114356', '13821172']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8327993544716109
- 35 USC 102 Novelty (BERT): 0.6464158264764085
- Combined Prediction Score: 0.8141610016720907
- Mean Citation Score: 641.993554
- Max Citation Score: 799.7855
- Similarity Product: 567.0769442321358

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test